13.07.2015 Views

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

IndexTreatment <strong>of</strong> nerve agent exposure. See also Field management <strong>of</strong>chemical casualties; Neuroprotection as a treatment for nerveagent survivors; specific nerve agents and drugsanticonvulsive therapy, 189–190antidote treatment nerve agent autoinjector, 182–186, 192, 193,194atropine therapy, 182–186, 244cardiac arrhythmia treatment, 190challenges <strong>of</strong> administration, 244, 253decontamination <strong>of</strong> the patient, 180–181effect <strong>of</strong> therapy on median lethal dose in monkeys exposed tosoman (table), 199general principles, 180–190, 244, 316mild exposure, 192minimal exposure, 191–192moderate exposure, 192moderately severe exposure, 192–193oxime therapy, 186–189, 197–198pediatric population and, 663–665pretreatment considerations, 197–204, 244protection <strong>of</strong> the rescuer, 180, 193psychogenic casualties and, 196recommended therapy for casualties <strong>of</strong> nerve agents (table),191regimen <strong>of</strong> antidotal therapy, 223, 244severe exposure, 193–194suspected exposure, 191terminating the exposure, 180–181timing <strong>of</strong> administration, 244, 252treatment by exposure category, 190–194value <strong>of</strong> aggressive treatment, 197ventilatory support, 181–182, 186“Treatment <strong>of</strong> Status Epilepticus in Adults: Columbia UniversityProtocol,” 231Treatment <strong>of</strong> toxic industrial chemical exposure. See also Fieldmanagement <strong>of</strong> chemical casualties; specific agents and drugsacute medical management, 362–365airway secretion management, 363–364clinical care, 365establishing an airway, 362–363history assessment for casualties exposed to lung-damagingagents (exhibit), 362hypotension treatment and prevention, 364–365hypoxia prevention and treatment, 364patient history, 361patient transport, 365physical assessment for casualties <strong>of</strong> lung-damaging chemicalagents (exhibit), 363physical examination, 361–362pulmonary edema treatment, 364rest from physical exertion, 363termination <strong>of</strong> exposure, 362triage for casualties <strong>of</strong> lung-damaging toxic industrial chemicals(exhibit), 364Treaty <strong>of</strong> Versaillesdescription, 136Trench mortarsattacks on the AEF (exhibit), 26CWS standardization <strong>of</strong>, 119–120description, 26Stokes mortars, 118, 119Triage <strong>of</strong> chemical casualtiesalternative areas for, 678benefit <strong>of</strong> assistance issues, 512–513challenges unique to, 516combined injuries and, 522–523conventional wounds contaminated with chemical agents,522–523cyanide and, 518–519, 521, 522, 523cyanide poisoning, 386decontamination, 513–514delayed treatment category, 516, 521, 577development <strong>of</strong> a pharmaceutical cache <strong>of</strong> medications, 678division triage stations, 94dynamic nature <strong>of</strong>, 513, 524emergent category, 516essential information for, 512evacuation issues, 516–517expectant treatment category, 516, 522, 577immediate treatment category, 516, 520–521, 577incapacitating agents and, 520, 521, 522, 523levels <strong>of</strong> care, 513lung-damaging agents and, 519–520, 522, 523medical management issues, 517–520minimal treatment category, 516, 521–522, 577national site setup and control zones for a hazardous materialssite (figure), 515natural course <strong>of</strong> disease and, 512–513nerve agents and, 518, 520–521, 522–523nonemergent category, 516pediatric population and, 677placement <strong>of</strong> teams, 514–516, 547principles and processes, 512–516, 524Sacco triage method, 517START system, 517treatment, decontamination, and transport linkage, 514–516triage and treatment area (cold zone), 506triage area (warm side), 504–505triage by category and agent, 520–522“triage” definition, 512triage for casualties <strong>of</strong> lung-damaging toxic industrial chemicals(exhibit), 364US military triage categories, 516–517vesicants and, 519, 521–522, 523Triazolamincapacitating effects, 420Trichloromethyl chlor<strong>of</strong>ormate. See ChloropicrinTrilon group <strong>of</strong> nerve agents. See Sarin; Soman; TabunTropical ataxic neuropathycyanide exposure and, 323Truman, Pres. Harry SUnited States ratification <strong>of</strong> the Geneva Protocol and, 60, 137Tsuchihashi, H.VX nerve agent research, 695TTX. See TetrodotoxinTurpin, Eugenesecret weapon developed by, 8022nd <strong>Chemical</strong> Battalionmission <strong>of</strong>, 59721st centuryOperation Enduring Freedom, 65Operation Iraqi Freedom, 65–66Russia’s use <strong>of</strong> fentanyl in the Chechen hostage situation, 3,65, 41320th Support Commanddomestic preparedness role, 7632-aminothiazoline-4-carboxylic acidcyanide poisoning and, 3762-chlorobenzylidene malonitrilenonmilitary uses, 342overall effects <strong>of</strong>, 342Yemen Civil War and, 3412-oxothiazolidine-4-carboxylic acidchemical structure (figure), 736lxiii

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!